Plain Language Summary of a Phase 2b Randomized Controlled Trial of Ecopipam and Its 12-Month Open-Label Extension in Children and Adolescents With Tourette Syndrome
Therapeutic Advances in Neurological Disorders
Published online on February 27, 2026
Abstract
Therapeutic Advances in Neurological Disorders, Volume 19, January-December 2026.
SummaryWhat is this summary about?The purpose of this summary is to explain the results from two studies that looked at the safety and effects of an investigational drug called ecopipam. “Investigational” means that the drug has not been approved by the ...
SummaryWhat is this summary about?The purpose of this summary is to explain the results from two studies that looked at the safety and effects of an investigational drug called ecopipam. “Investigational” means that the drug has not been approved by the ...